Skip to content
About
Company Overview
Our Team
Scientific Approach
Our Engineering
Our Platform
Pipeline & Programs
Our Pipeline
GNTI-122
POLARIS Study
News
Genti in the News
Publications
Conference Presentations
Contact
Locations
Careers
Toggle navigation
About
Company Overview
Our Team
Scientific Approach
Our Engineering
Our Platform
Pipeline & Programs
Our Pipeline
GNTI-122
POLARIS Study
News
Genti in the News
Publications
Conference Presentations
Contact
Locations
Careers
Genti Publication
April 17, 2025
CAR19 EngTregs offer broad capacity to modulate immune tolerance and improve safety in B and T cell mediated autoimmune disorders
Click here to download PDF
‹ Back to Publications